Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT00688116
Show Display Options
Rank Status Study
1 Active, not recruiting Study of STA-9090, Administered Twice-Weekly in Patients With Solid Tumors
Condition: Solid Tumors
Intervention: Drug: STA 9090 (ganetespib)

Indicates status has not been verified in more than two years